mardi 25 novembre 2014

Pathology specialist contributes to debate on breast cancer gene screening

What are the risks and benefits of screening for BRCA1 and BRCA2 mutations in the general adult population? An expert has published an invited commentary on this issue.

Pathology specialist contributes to debate on breast cancer gene screening

Aucun commentaire:

Enregistrer un commentaire